Advancing UK Regulatory Science Strategy in the Context of Global Regulation: a Stakeholder Survey.

Samantha Cruz RiveraBarbara TorlinskaEliot MarstonAlastair K DennistonKathy OliverSteve HoareMelanie Jane Calvert

Published in: Therapeutic innovation & regulatory science (2021)

The UK has a time-critical opportunity to establish its national and international strategy for regulatory science leadership by harnessing broader academic input, developing strategic cross-sector collaborations, incorporating patients' experiences and perspectives, and investing in a skilled workforce.

Keyphrases

public health
cross sectional
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
quality improvement